Table 2.
Hepatic content of lycopene metabolites, total lycopene, and its isomers, and liver weight in the four experimental groups, at the end of the 5-week intervention period 1.
| Parameters | NA | NL | HA | HL |
|---|---|---|---|---|
| 6-apo-lycopenal | nd | nd | Nd | nd |
| 8-apo-lycopenal | nd | nd | Nd | nd |
| 12-apo-lycopenal | nd | nd | Nd | nd |
| 9-cis lycopene (µg/g) | nd | 0.54 ± 0.10 | Nd | 0.81 ± 0.15 |
| 13-cis lycopene (µg/g) | nd | 0.51 ± 0.26 * | Nd | 0.25 ± 0.12 |
| Trans-lycopene (µg/g) | nd | 1.71 ± 0.30 | Nd | 3.49 ± 1.79 * |
| Total lycopene (µg/g) | nd | 2.75 ± 0.33 | Nd | 4.55 ± 0.80 * |
| Liver weight (g) | 11.91 ± 1 b | 12.82 ± 1.31 b | 22.74 ± 2.66 a | 24.12 ± 2.72 a |
1 Values are given as mean ± SD. * Indicates a statistically significant difference between the NL and HL groups according to a paired t-test (p < 0.05). a,b Different letters in the same row indicate significant differences for p < 0.05.